152 related articles for article (PubMed ID: 6302161)
1. Evidence for a therapeutic effect of dl-propranolol in benign and malignant insulinoma: report of three cases.
Blum I; Rusecki Y; Doron M; Lahav M; Laron Z; Atsmon A
J Endocrinol Invest; 1983 Feb; 6(1):41-5. PubMed ID: 6302161
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment for inoperable insulinoma: clinical usefulness of diphenylhydantoin and diltiazem.
Imanaka S; Matsuda S; Ito K; Matsuoka T; Okada Y
Jpn J Clin Oncol; 1986 Mar; 16(1):65-71. PubMed ID: 3009920
[TBL] [Abstract][Full Text] [Related]
3. Suppression of hypoglycemic attacks and insulin release by propranolol in a patient with metastatic malignant insulinoma.
Shaklai M; Aderka D; Blum I; Laron Z; Asherov J; Doron M; Atsmon A; Pinkhas J
Diabete Metab; 1977 Sep; 3(3):155-8. PubMed ID: 199483
[No Abstract] [Full Text] [Related]
4. Streptozotocin effective for treating multiple-hormone-producing malignant islet cell tumor.
Murata E; Tashiro S; Hiraoka T
Jpn J Surg; 1985 Jan; 15(1):63-7. PubMed ID: 2985854
[TBL] [Abstract][Full Text] [Related]
5. Prevention of hypoglycemic attacks by propranolol in a patient suffering from insulinoma.
Blum I; Doron M; Laron Z; Atsmon A; Tiqva P
Diabetes; 1975 Jun; 24(6):535-7. PubMed ID: 166895
[TBL] [Abstract][Full Text] [Related]
6. [Effect of propranolol on the blood sugar immunoreactive blood insulin in a patient with insulinoma].
Neri V; Bartorelli A; Faglia G
Acta Diabetol Lat; 1969; 6(4):809-19. PubMed ID: 4321785
[No Abstract] [Full Text] [Related]
7. Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.
Glaser B; Rösler A; Halperin Y
Isr J Med Sci; 1990 Jan; 26(1):16-9. PubMed ID: 2155884
[TBL] [Abstract][Full Text] [Related]
8. Insulinoma in a 94-year-old woman: long-term therapy with verapamil.
Ulbrecht JS; Schmeltz R; Aarons JH; Greene DA
Diabetes Care; 1986; 9(2):186-8. PubMed ID: 3009112
[TBL] [Abstract][Full Text] [Related]
9. Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma.
Osei K; Falko JM; Nelson KP; Stephens R
Am J Med; 1984 Jul; 77(1):41-6. PubMed ID: 6331162
[TBL] [Abstract][Full Text] [Related]
10. Diazoxide infusion test in patients with single benign insulinoma.
Tamburrano G; Lala A; Mauceri M; Leonetti F; Libianchi S; Andreani D
Horm Res; 1983; 17(3):141-6. PubMed ID: 6303933
[TBL] [Abstract][Full Text] [Related]
11. Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin).
Stehouwer CD; Lems WF; Fischer HR; Hackeng WH; Naafs MA
Acta Endocrinol (Copenh); 1989 Jul; 121(1):34-40. PubMed ID: 2545062
[TBL] [Abstract][Full Text] [Related]
12. Remission of symptoms of chemotherapy-refractory metastatic insulinoma using octreotide.
Longnecker SM
Drug Intell Clin Pharm; 1988 Feb; 22(2):136-8. PubMed ID: 2894965
[TBL] [Abstract][Full Text] [Related]
13. The effect of propranolol on hypoglycaemia. Observations in five insulinoma patients.
Scandellari C; Zaccaria M; De Palo C; Sicolo N; Erle G; Federspil G
Diabetologia; 1978 Oct; 15(4):297-301. PubMed ID: 213332
[TBL] [Abstract][Full Text] [Related]
14. Glucose intolerance in a patient with insulinoma. Report of a case.
Christiansen J; Munkgaard S
Acta Chir Scand; 1974; 140(7):578-80. PubMed ID: 4376322
[No Abstract] [Full Text] [Related]
15. Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.
Osei K; O'Dorisio TM
Ann Intern Med; 1985 Aug; 103(2):223-5. PubMed ID: 2861769
[No Abstract] [Full Text] [Related]
16. Malignant metastatic insulinoma treated with streptozotocin.
Gefel A; Flatau E; Ayalon D; Papo J; Loewenthal M
Clin Endocrinol (Oxf); 1975 Sep; 4(5):461-8. PubMed ID: 170028
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin.
Rizza RA; Haymond MW; Verdonk CA; Mandarino LJ; Miles JM; Service FJ; Gerich JE
Diabetes; 1981 May; 30(5):377-81. PubMed ID: 6262168
[TBL] [Abstract][Full Text] [Related]
18. Use of euglycaemic clamping in evaluation of diazoxide treatment of insulinoma.
Skrha J; Svacina S; Srámková J; Páv J
Eur J Clin Pharmacol; 1989; 36(2):199-201. PubMed ID: 2542036
[TBL] [Abstract][Full Text] [Related]
19. Relapse of medically treated insulinoma following the development of thyrotoxicosis: an assessment of potential mechanisms.
Walker M; Trajano LR; Alberti KG; Kendall-Taylor P
Thyroid; 1994; 4(1):73-6. PubMed ID: 8054864
[TBL] [Abstract][Full Text] [Related]
20. Effect of propranolol on glucose-induced insulin response in rats with insulinomas.
Yoshino G; Kazumi T; Morita S; Kobayashi N; Terashi K; Baba S
Endocrinol Jpn; 1980 Dec; 27(6):775-8. PubMed ID: 6266820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
